ZOM
Zomedica Corp.
No insider bought or sold Zomedica Corp. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
ZOM over the last year
Prices for ZOM aren't in yet.
ZOM after insider buys
3 months after each buy, from the first price a copier could get.
−9.6%Average
−12.8 ptsVs S&P 500
0 of 3Higher
3 buys since 2021 with 3 months of prices.
Every filing
17 insider filings since 2018, newest first
ZOMBuy
Jeffrey M Rowe · Director
$96K+12.0%Mar 27
ZOMBuy
Larry C Heaton II · CEO
$30K+100.0%Mar 18
ZOMBuy
Johnny D Powers · Director
$34K+10.0%Mar 18
ZOMBuy
Anthony K Blair · COO
$30K+125.0%Mar 18
ZOMBuy
Russell Kevin Klass · SVP of Sales
$49K+28.0%Mar 18
ZOMBuy
Russell Kevin Klass · VP of Sales
$60K+50.0%Nov 12
ZOMBuy
Russell Kevin Klass · VP of Sales
$47K+18.0%Jun 13
ZOMBuy
Russell Kevin Klass · VP of Sales
$105K+70.0%Jun 12
ZOMBuy
Johnny D Powers · Director
$113K+20.0%Nov 22
ZOMSell
Robert Cohen · CEO
$447K−100.0%Jun 30
ZOMSell
Johnny D Powers · Director
$117K−9.0%Jun 16
ZOMSell
Robert Cohen · CEO
$2.6M−100.0%Jun 1
ZOMSell
Johnny D Powers · Director
$97K−9.0%May 17
ZOMSell
Johnny D Powers · Director
$868K−38.0%Apr 13
ZOMSell
Stephanie Morley · President and CMO
$931K−35.0%Apr 13
ZOMSell
Ann Marie Cotter · CFO and Secretary
$67K−100.0%Apr 13
ZOMSell
James Lebar · Director
$430K−91.0%Aug 30
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.